Dual Pathway Inhibition Versus Dual Antiplatelet Therapy Following Isolated Tibial Balloon Angioplasty for Chronic Limb-Threatening Ischemia.

Abdelmalak M, Abdelaziz I, Abdulaal U, Rabee H, Algaby A.

Open source

DOI
10.1016/j.jvs.2026.08.033
Published
2026-09-08
Container
J Vasc Surg
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jvs.2026.08.033,
  title = {Dual Pathway Inhibition Versus Dual Antiplatelet Therapy Following Isolated Tibial Balloon Angioplasty for Chronic Limb-Threatening Ischemia.},
  author = {Abdelmalak M and  Abdelaziz I and  Abdulaal U and  Rabee H and  Algaby A.},
  year = {2026},
  journal = {J Vasc Surg},
  doi = {10.1016/j.jvs.2026.08.033},
  url = {https://doi.org/10.1016/j.jvs.2026.08.033}
}

RIS

TY  - JOUR
TI  - Dual Pathway Inhibition Versus Dual Antiplatelet Therapy Following Isolated Tibial Balloon Angioplasty for Chronic Limb-Threatening Ischemia.
AU  - Abdelmalak M
AU  -  Abdelaziz I
AU  -  Abdulaal U
AU  -  Rabee H
AU  -  Algaby A.
PY  - 2026
JO  - J Vasc Surg
DO  - 10.1016/j.jvs.2026.08.033
UR  - https://doi.org/10.1016/j.jvs.2026.08.033
ER  - 

APA

M, A., I, A., U, A., H, R., & A., A. (2026). Dual Pathway Inhibition Versus Dual Antiplatelet Therapy Following Isolated Tibial Balloon Angioplasty for Chronic Limb-Threatening Ischemia.. J Vasc Surg. https://doi.org/10.1016/j.jvs.2026.08.033

Source records